{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:55:59Z","timestamp":1771512959126,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel antiviral agents and in the repurposing of existing agents with demonstrated efficacy against other known coronaviruses in the search for an agent with antiviral activity for use during the COVID-19 pandemic. Adamantanes including amantadine, rimantadine, and memantine have well-established benefit in the treatment of neurodegenerative diseases including Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD) and fatigue related to Multiple sclerosis (MS) all of which are known comorbidities related to COVID-19 Moreover, results of basic pharmacological studies both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> reveal that amantadine has the potential to inhibit SARS-CoV-2 <jats:italic>via<\/jats:italic> down-regulation of host-cell proteases resulting in impaired viral genome release into the host cell and <jats:italic>via<\/jats:italic> amantadine\u2019s property as an NMDA receptor antagonist resulting in the prevention of the acute lung injury and respiratory distress that is characteristic of COVID-19. Cases suggestive of COVID-19 prophylaxis have been reported in patients with PD or MS or severe cognitive impairment treated in all cases for several months with an adamantane [amantadine or memantine] who were subsequently infected with SARS-CoV-2 confirmed by RT-PCR, and, in all cases, no signs of infectious disease were encountered. Amantadine is effective for the treatment of fatigue in MS and for the neurological complications of Traumatic Brain Injury (TBI).<\/jats:p>","DOI":"10.3389\/fnins.2023.1128157","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T06:47:36Z","timestamp":1678258056000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2"],"prefix":"10.3389","volume":"17","author":[{"given":"Roger F.","family":"Butterworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jalz.2012.07.005","article-title":"Intracerebral propagation of Alzheimer\u2019s disease: strengthening evidence of a herpes simplex virus etiology.","volume":"9","author":"Ball","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1128\/JVI.02972-13","article-title":"Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus.","volume":"88","author":"Brison","year":"2014","journal-title":"J. Virol."},{"key":"B3","article-title":"Amantadine for the treatment of Parkinson\u2019s disease and its associated dyskinesias.","volume":"7","author":"Butterworth","year":"","journal-title":"J. Parkinsons Dis. Alzheimer Dis."},{"key":"B4","first-page":"1","article-title":"Amantadine, Parkinson\u2019s disease and COVID-19.","volume":"1","author":"Butterworth","year":"","journal-title":"Covid Perspect. Res. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2018.5738","article-title":"Amantadine for the treatment of traumatic brain injury and its associated cognitive and neurobehavioural complications.","volume":"3","author":"Butterworth","year":"","journal-title":"Pharmacol. Pharm. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40268-021-00351-6","article-title":"Potential for the Repurposing of Adamantane Antivirals for COVID-19.","volume":"21","author":"Butterworth","year":"2021","journal-title":"Drugs R D."},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.37532\/22.4.2.17-20","article-title":"Memantine for the treatment of Alzheimer\u2019s disease: novel mechanisms and future opportunities.","volume":"4","author":"Butterworth","year":"2022","journal-title":"Neurol. Neurorehabil."},{"key":"B8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s004150070148","article-title":"MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue.","volume":"247","author":"Colombo","year":"2000","journal-title":"J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2008.01.018","article-title":"Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI.","volume":"270","author":"DeLuca","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.2992088","article-title":"Infection of the basal ganglia by a murine coronavirus.","volume":"229","author":"Fishman","year":"1985","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078811","article-title":"Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging.","volume":"8","author":"Genova","year":"2013","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1212\/WNL.0000000000005926","article-title":"Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.","volume":"91","author":"Giacino","year":"2018","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer\u2019s disease: an updated systematic review and meta-analysis.","volume":"60","author":"Kishi","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"57316","DOI":"10.18632\/oncotarget.17622","article-title":"An updated meta-analysis of amantadine for treating dyskinesia in Parkinson\u2019s disease.","volume":"8","author":"Kong","year":"2017","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/02699050400025059","article-title":"Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET).","volume":"9","author":"Kraus","year":"2005","journal-title":"Brain Inj."},{"key":"B16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-85-2-177","article-title":"Amantadine effect on peripheral airways abnormalities in influenza.","volume":"85","author":"Little","year":"1976","journal-title":"Ann. Int. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2.","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B18","article-title":"Amantadine for the treatment of fatigue in multiple sclerosis: systematic review and summary of the evidence base.","volume":"8","author":"Pilling","year":"2021","journal-title":"J. Mult. Sclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/mds.28088","article-title":"Parkinson\u2019s disease and COVID-19: Perceptions and implications in patients and caregivers.","volume":"35","author":"Prasad","year":"2020","journal-title":"Mov. Disord."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102163","article-title":"Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.","volume":"42","author":"Rejdak","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1212\/wnl.48.6.1566","article-title":"Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.","volume":"48","author":"Roelcke","year":"1997","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","article-title":"Amantadine in the treatment of Parkinson\u2019s disease.","volume":"208","author":"Schwab","year":"1969","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbrc.2020.05.206","article-title":"SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.","volume":"530","author":"Singh Tomar","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106004","article-title":"Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.","volume":"55","author":"Smieszek","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1084\/jem.181.6.2161","article-title":"The substantia nigra is a major target for neurovirulent influenza A virus.","volume":"181","author":"Takahashi","year":"1995","journal-title":"J. Exp. Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02866-9","article-title":"Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.","volume":"4","author":"Toft-Bertelsen","year":"2021","journal-title":"Commun. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/npp.2009.64","article-title":"Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.","volume":"34","author":"Wu","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other.","volume":"10","author":"Xia","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/v13102082","article-title":"Efficacy of ion-channel inhibitors amantadine, memantine and rimantadine for the treatment of SARS-CoV-2 in vitro.","volume":"13","author":"Zhou","year":"2021","journal-title":"Viruses"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1128157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T06:47:41Z","timestamp":1678258061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1128157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":29,"alternative-id":["10.3389\/fnins.2023.1128157"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1128157","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1128157"}}